However, due to (i) rareness of the disease (unfamiliar to most neurologists), (ii) non-inclusion of GNE genetic testing for neurological indications, and (iii) non-specific symptoms at disease onset (foot-drop, balance impairment), the diagnosis of these patients is difficult and often delayed
selective bottom-up checks, such as sampled manufacturer sales and online unit estimates, validate totals
Its long-acting profile enables more sustained activation of IGF-1 receptors, making it ideal for longitudinal studies
It's also important to recognise that unrealistic expectations can lead to perceived treatment failure
Mechanism of Action: What Does BPC 157 Do
Some GLP-1 antagonists can also help treat obesity